3 ms·
This is a big issue. Clinical studies to get a chemical approved for therapeutical use are very expensive, and since most of the chemicals were first explored
by PeterisP 9y ago
This is a big issue. Clinical studies to get a chemical approved for therapeutical use are very expensive, and since most of the chemicals were first explored a long time ago, they can't be patented anymore, so no pharmaceutical company would fund the studies since they won't be able to be the sole provider of that drug (at a premium cost), and public funding for clinical studies is quite low.
- metalliqaz 9y agoI guess that leaves academia?
- PeterisP 9y agoNo, it does not. "Academia" generally means studies funded by public grants (which, as I said above, very rarely would cover drug approval studies) and in some cases academia might implement studies funded by the pharmaceutical companies, but they're not really an independent source of funding for research, at least not in expensive/labor intensive fields like medicine. In fields where solid research can't be done by a single part-time person (e.g. a teaching professor), research happens only to the extent and in the direction where there's available funding. Even putting a couple grad students on a project for a year (i.e., a very small project) requires external funding, much less the extensive studies needed to prove that a particular chemical is safe for human use and has a therapeutic effect.
- refurb 9y agoThere is nothing stopping them from making a patentable analogue. Happens a lot right now.
- joecool1029 9y agoWell, except for this: https://en.wikipedia.org/wiki/Federal_Analogue_Act https://en.wikipedia.org/wiki/Federal_Analogue_Act
- refurb 9y agoMeh... that already isn't a barrier. Analogues of heroin (fentanyl, etc) are legitimate Rx drugs today.